Document Detail


Neuro-oncology: a selected review of ASCO 2011 abstracts.
MedLine Citation:
PMID:  21955193     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
American Society of Clinical Oncology (ASCO), the largest clinical oncology meeting in the USA, meets annually and consistently provides an exciting forum to present new cancer clinical trials and research data. The ASCO 2011 neuro-oncology session, comprising of 3 days of presentations and over 100 abstracts, provided an overview of neuro-oncology, including both metastatic diseases of the CNS and primary brain tumors. This brief article attempts to highlight select abstracts presented at this years meeting in an organizational manner that will hopefully provide a portrait of the large and multifaceted meeting.
Authors:
Marc C Chamberlain
Related Documents :
7862303 - Anonymous grading: an ethical teaching strategy.
21030473 - The transformation of (bio)ethics expertise in a world of ethical pluralism.
4913493 - A survey of infantile gastroenteritis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of neurotherapeutics     Volume:  11     ISSN:  1744-8360     ISO Abbreviation:  Expert Rev Neurother     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-09-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101129944     Medline TA:  Expert Rev Neurother     Country:  England    
Other Details:
Languages:  eng     Pagination:  1371-7     Citation Subset:  IM    
Affiliation:
Departments of Neurology and Neurological Surgery, Division of Neuro-Oncology, University of Washington, Fred Hutchinson Research Cancer Center, Seattle Cancer Care Alliance, 825 Eastlake Avenue East, Mailstop: G4-940, Seattle, WA 98109-1023, USA. chambemc@u.washington.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of memantine for the treatment of dementia.
Next Document:  Recent advances in headache research.